Musculoskeletal Disorders
News from the FDA/CDC
FDA approves first tocilizumab biosimilar
Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.
Letters from Maine
Pain mismanagement by the numbers
Pain is a complex, multifaceted phenomenon. Distilling a person’s pain experience to a single number doesn’t make sense, nor does reflexly...
Feature
Humira biosimilars: Five things to know
The launch of eight adalimumab biosimilars so far in 2023 ended Humira’s 20-year monopoly, but it’s not clear yet if these discounted drugs will...
Guidelines
Systemic JIA and AOSD are the same disease, EULAR says
New recommendations state that the ultimate goal of treatment should be drug-free remission.
Conference Coverage
Answers sought for mental health challenges in pediatric rheumatology patients
One study found a tremendous increase in screening by automating the process while another found remote delivery of a 6-week cognitive-behavioral...
Conference Coverage
Parents of patients with rheumatic disease, MIS-C strongly hesitant of COVID vaccination
A single-center study and a survey of rheumatologists revealed similar levels of hesitancy among parents of both these populations.
Conference Coverage
Pretransfer visits with pediatric and adult rheumatologists smooth adolescent transition
The time from the last pediatric visit to the first adult visit was substantially shorter for patients who had a dual provider pretransfer visit...
Conference Coverage
Little change in rheumatology faculty coverage in pediatric residency programs in nearly 20 years
There has been little improvement in addressing the shortage of pediatric rheumatologists over the past 2 decades, boding poorly for future...
Feature
Biosimilars and patients: Discussions should address safety, cost, and anxiety about change
Physicians can respond to pushback from patients on switching to a biosimilar by offering resources and discussing options for both biosimilar and...
From the Journals
Abnormal bleeding common among youth with joint hypermobility
Study suggests that children with generalized joint hypermobility should be routinely screened for abnormal bleeding symptoms and referred as...
Latest News
AAP issues clinical update to cerebral palsy guidelines
Pediatricians urged to formalize standard developmental screens, refer motor delays early.